Docoh
Loading...

DARE Dare Bioscience

Employees

Data from SEC filings
Employee count

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
At the annual meeting of stockholders of Daré Bioscience, Inc. ("Daré," “we,” “us,” or “our”) held on June 24, 2021, five proposals were voted upon by Daré’s stockholders. The proposals are described in detail in our definitive proxy statement for the annual meeting, filed with the Securities and Exchange Commission on May 14, 2021. Below is a brief description of, and the final results of the votes for, each proposal:

1.Our stockholders elected the nominees named below to our board of directors to serve as Class I directors for a three-year term expiring at our 2024 annual meeting of stockholders by the votes set forth below:

NomineeVotes ForVotes WithheldBroker Non-Votes
Jessica D. Grossman, M.D.10,287,8331,872,95715,613,671
Susan L. Kelley, M.D.10,290,8291,869,96115,613,671
Sophia Ononye-Onyia, Ph.D.10,618,1071,542,68315,613,671


2.Our stockholders ratified the appointment of Mayer Hoffman McCann P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2021 by the votes set forth below:

Votes ForVotes AgainstAbstentionsBroker Non-Votes
27,083,303595,80195,357--


3.Our stockholders approved the issuance of shares of our common stock in connection with an acquisition for purposes of complying with Nasdaq Listing Rule 5635 by the votes set forth below:

Votes ForVotes AgainstAbstentionsBroker Non-Votes
10,232,3521,882,82145,61715,613,671


4.Our stockholders approved, on an advisory basis, the 2020 compensation of our named executive officers by the votes set forth below:

Votes ForVotes AgainstAbstentionsBroker Non-Votes
9,871,5542,111,802177,43415,613,671


5.Our stockholders approved the adjournment of the meeting, if necessary or advisable, to solicit additional proxies in favor of Proposal 3 if there are not sufficient votes to approve Proposal 3:

Votes ForVotes AgainstAbstentionsBroker Non-Votes
24,806,4912,581,778386,192--